New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
基本信息
- 批准号:10846315
- 负责人:
- 金额:$ 10.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAdultAreaBlood VesselsBostonCaringChildChildhood strokeClinical InvestigatorClinical ResearchClinical TrialsClinical Trials NetworkClinical and Translational Science AwardsCollaborationsDisciplineEmergency MedicineEnrollmentFundingGeneral HospitalsGeographyHealthHospitalsInfrastructureInternationalInvestigationIsraelLeadershipMassachusettsMedical centerMulticenter TrialsNational Institute of Neurological Disorders and StrokeNeurologicNeurologyNew EnglandNew HampshirePatient CarePediatric HospitalsPerformancePhasePositioning AttributePrincipal InvestigatorRecordsRehabilitation therapyResearchResearch InfrastructureResearch InstituteResearch PersonnelResourcesRoleSeasonsSiteStrokeStrokeNet clinical trialsStrokeNet trialsTalentsTranslational ResearchUnited States National Institutes of HealthUniversitiesVermontVisionWomanclinical translationinnovationmembermetropolitanneuroimagingneurosurgerypatient populationpre-clinicalprogramsrecruitskillsstroke neurologystroke rehabilitationstroke trialssuburbtelestroke
项目摘要
PROJECT SUMMARY/ABSTRACT
We propose to continue the StrokeNet New England Regional Coordinating Center (NERCC), an integrated
team of hospitals in the Greater Boston Area and suburbs, Western Massachusetts, New Hampshire and
Vermont that will serve as a top-enrolling site and vibrant contributor to the NINDS StrokeNet Clinical Trials
Network. Our group includes most of the major academic adult and pediatric stroke and rehabilitation hospitals
in Massachusetts, New Hampshire and Vermont. Our 30+ hospital New England TeleStroke referral network
will extend our potential recruitment and become particularly relevant with the upcoming STEP platform trials.
All core hospitals have a proven track record of successful management and performance of clinical trials. In
particular, all hospitals have an established research infrastructure that performs ongoing clinical research in
stroke neurology with strong collaborations across multiple disciplines. The leadership team composed of
Principal investigator Aneesh Singhal, MD, Deputy PI Natalia Rost MD, MPH, Site PIs, Deputy Site PIs, and
Co-Investigators bring a diverse and complementary set of skills in managing successful translational clinical
research programs, serving as members on trial Steering Committees, and positions of national leadership in
their fields. Our team includes seasoned clinical investigators in vascular neurology, emergency medicine,
neuroendovascular, neurosurgery, neurointensive care, neuroimaging, stroke rehabilitation, and preclinical
basic and translational stroke investigation in both adults and children. Strengths of the NERCC team include
1) close personal and professional ties between multiple investigators and site PIs; 2) a large patient
population with geographically diverse hospital settings anchored in a major metropolitan area; 3) talented
teams of site investigators with track records of scientific achievement, innovation, and subject recruitment in
multicenter trials; 4) robust existing NINDS-funded research and clinical trial management infrastructure at
most of the sites; 5) existing clinical research programs, e.g., MGH Neurological Clinical Research Institute,
NIH Clinical and Translational Science Award programs serving Boston University and all Harvard hospitals;
and 6) leadership roles in the SIREN-NETT, NeuroNEXT, DISCOVERY and MarkVCID trial networks. Overall,
the NERCC Team has demonstrated outstanding commitment and performance in the first two StrokeNet
cycles, and has the resources, vision, and enthusiasm to continue to develop new translational science and
successfully execute the NINDS StrokeNet Phase 1,2 and 3 trials.
项目总结/文摘
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Legislation Increased Medicare Telestroke Billing, But Underbilling And Erroneous Billing Remain Common.
- DOI:10.1377/hlthaff.2021.00791
- 发表时间:2022-03
- 期刊:
- 影响因子:9.7
- 作者:Wilcock, Andrew D.;Schwamm, Lee H.;Zubizarreta, Jose R.;Zachrison, Kori S.;Uscher-Pines, Lori;Majersik, Jennifer J.;Richard, Jessica, V;Mehrotra, Ateev
- 通讯作者:Mehrotra, Ateev
Insurance-Based Disparities in Stroke Center Access in California: A Network Science Approach.
加州中风中心访问中基于保险的差异:网络科学方法。
- DOI:10.1161/circoutcomes.122.009868
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Zachrison,KoriS;Hsia,ReneeY;Schwamm,LeeH;Yan,Zhiyu;Samuels-Kalow,MargaretE;Reeves,MathewJ;CamargoJr,CarlosA;Onnela,Jukka-Pekka
- 通讯作者:Onnela,Jukka-Pekka
Regional Changes in Patterns of Stroke Presentation During the COVID-19 Pandemic.
- DOI:10.1161/strokeaha.120.031300
- 发表时间:2021-04
- 期刊:
- 影响因子:8.3
- 作者:Etherton MR;Zachrison KS;Yan Z;Sveikata L;Bretzner M;Estrada J;Viswanathan A;Singhal AB;Schwamm LH
- 通讯作者:Schwamm LH
Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure.
- DOI:10.1161/strokeaha.121.034622
- 发表时间:2021-12
- 期刊:
- 影响因子:8.3
- 作者:Lusk JB;Xu H;Peterson ED;Bhatt DL;Fonarow GC;Smith EE;Matsouaka R;Schwamm LH;Xian Y
- 通讯作者:Xian Y
Temporal Trends in Racial and Ethnic Disparities in Endovascular Therapy in Acute Ischemic Stroke.
- DOI:10.1161/jaha.121.023212
- 发表时间:2022-03-15
- 期刊:
- 影响因子:5.4
- 作者:Sheriff, Faheem;Xu, Haolin;Maud, Alberto;Gupta, Vikas;Vellipuram, Anantha;Fonarow, Gregg C.;Matsouaka, Roland A.;Xian, Ying;Reeves, Mathew;Smith, Eric E.;Saver, Jeffrey;Rodriguez, Gustavo;Cruz-Flores, Salvador;Schwamm, Lee H.
- 通讯作者:Schwamm, Lee H.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANEESH B SINGHAL其他文献
ANEESH B SINGHAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANEESH B SINGHAL', 18)}}的其他基金
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
10457482 - 财政年份:2018
- 资助金额:
$ 10.42万 - 项目类别:
Indo-US Collaborative Stroke Registry and Infrastructure Development
印度-美国合作卒中登记和基础设施开发
- 批准号:
8337854 - 财政年份:2011
- 资助金额:
$ 10.42万 - 项目类别:
Indo-US Collaborative Stroke Registry and Infrastructure Development
印度-美国合作卒中登记和基础设施开发
- 批准号:
8242941 - 财政年份:2011
- 资助金额:
$ 10.42万 - 项目类别:
相似海外基金
History of Community and Adult Education in Old Coal Mining Area in Northern Kyushu
九州北部老煤矿区社区与成人教育的历史
- 批准号:
26780447 - 财政年份:2014
- 资助金额:
$ 10.42万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
High Risk Adult Hepatitis B Vaccination Pilot -Program Area 7
高危成人乙型肝炎疫苗接种试点 - 计划领域 7
- 批准号:
8506903 - 财政年份:2012
- 资助金额:
$ 10.42万 - 项目类别:
The San Francisco Bay Area Adult Glioma Survival Study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7253800 - 财政年份:2007
- 资助金额:
$ 10.42万 - 项目类别:
San Francisco Bay area adult glioma survival study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
6686704 - 财政年份:2002
- 资助金额:
$ 10.42万 - 项目类别:
The San Francisco Bay Area Adult Glioma Survival Study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
8258656 - 财政年份:
- 资助金额:
$ 10.42万 - 项目类别:
San Francisco Bay area adult glioma survival study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7550487 - 财政年份:
- 资助金额:
$ 10.42万 - 项目类别:
The San Francisco Bay Area Adult Glioma Survival Study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
8099448 - 财政年份:
- 资助金额:
$ 10.42万 - 项目类别:
San Francisco Bay area adult glioma survival study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7550482 - 财政年份:
- 资助金额:
$ 10.42万 - 项目类别:
The San Francisco Bay Area Adult Glioma Survival Study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7885642 - 财政年份:
- 资助金额:
$ 10.42万 - 项目类别:
San Francisco Bay area adult glioma survival study
旧金山湾区成人神经胶质瘤生存研究
- 批准号:
7550492 - 财政年份:
- 资助金额:
$ 10.42万 - 项目类别: